title: The development of non-toxic ionic-crosslinked chitosan-based microspheres as carriers for the controlled release of silk sericin.
abstract: Silk sericin is recently shown to possess various biological activities for biomedical applications. While various sericin carriers were developed for drug delivery system, very few researches considered sericin as a bioactive molecule itself. In this study, sericin incorporated in the chitosan-based microspheres was introduced as a bioactive molecule and bioactive carrier at the same time. The chitosan/sericin (CH/SS) microspheres at different composition (80/20, 70/30, 60/40, and 50/50) were successfully fabricated using anhydroustri-polyphosphate (TPP) as a polyanionic crosslinker. The microspheres with an average size of 1-4 μm and narrow size distribution were obtained. From FT-IR spectra, the presence of both chitosan and sericin in the microspheres confirmed the occurrence of ionic interaction that crosslink them within the microspheres. We also found that the CH/SS microspheres prepared at 50/50 could encapsulate sericin at the highest percentage (37.28%) and release sericin in the most sustained behavior, possibly due to the strong ionic interaction of the positively charged chitosan and the negatively charged sericin. On the other hand, the composition of CH/SS had no effect on the degradation rate of microspheres. All microspheres continuously degraded and remained around 20% after 14 days of enzymatic degradation. This explained that the ionic crosslinkings between chitosan and sericin could be demolished by the enzyme and hydrolysis. Furthermore, we have verified that all CH/SS microspheres at any concentrations showed non-toxicity to L929 mouse fibroblast cells. Therefore, we suggested that the non-toxic ionic-crosslinked CH/SS microspheres could be incorporated in wound dressing material to achieve the sustained release of sericin for accelerated wound healing.
authors.affiliation: Bioactive Resources for Innovative Clinical Applications Research Unit and Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, PhayaThai Road, Phatumwan, Bangkok, 10330, Thailand, aramwit@gmail.com.
authors.forename: Pornanong
authors.initials: P
authors.lastname: Aramwit
authors.forename: Sanong
authors.initials: S
authors.lastname: Ekasit
authors.forename: Rungnapha
authors.initials: R
authors.lastname: Yamdech
mesh_terms: D000818:Animals; D002214:Capsules / Q000737:chemistry* / Q000633:toxicity; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D048271:Chitosan / Q000737:chemistry / Q000633:toxicity; D003432:Cross-Linking Reagents / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000737:chemistry* / Q000633:toxicity; D004058:Diffusion; D015195:Drug Design; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects* / Q000502:physiology; D007477:Ions; D051379:Mice; D011122:Polyphosphates / Q000737:chemistry; D047030:Sericins / Q000008:administration & dosage* / Q000737:chemistry* / Q000633:toxicity
chemical_list: D002214:Capsules; D003432:Cross-Linking Reagents; D003692:Delayed-Action Preparations; D007477:Ions; D011122:Polyphosphates; D047030:Sericins; D048271:Chitosan